| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.06 |